Adiposity and Chronic Inflammation in Young Women Predict Inflammation during Normal Pregnancy in the Philippines by McDade, Thomas W. et al.
The Journal of Nutrition
Community and International Nutrition
Adiposity and Chronic Inflammation in Young
Women Predict Inflammation during Normal
Pregnancy in the Philippines1–3
Thomas W McDade,4,5* Judith B Borja,6,7 Fe Largado,6 Linda S Adair,8 and Christopher W Kuzawa4
4Department of Anthropology and Institute for Policy Research, Northwestern University, Evanston, IL; 5Child and Brain Development
Program, Canadian Institute for Advanced Research, Toronto, Canada; 6University of San Carlos Office of Population Studies
Foundation, Inc., and 7Department of Nutrition and Dietetics, University of San Carlos, Cebu City, Philippines; and 8Carolina Population
Center and Department of Nutrition, University of North Carolina, Chapel Hill, Chapel Hill, NC
Abstract
Background: Rates of overweight and obesity are on the rise globally, and excess adipose tissue may contribute to
elevations in inflammation during pregnancy, leading to pregnancy complications and adverse birth outcomes.
Objective: The purpose of this study was to evaluate adiposity and inflammation in young women as predictors of
inflammation in the third trimester of pregnancy in a community-based sample of healthy women.
Methods: Female participants (24–30 y) in a prospective observational cohort study (Cebu Longitudinal Health and
Nutrition Survey) were contacted between 2009 and 2014 to identify new pregnancies. A total of 309 women provided
data from 409 pregnancies. An in-home interview was scheduled for the third trimester to collect pregnancy informa-
tion, anthropometric measurements, and a blood sample. Circulating C-reactive protein (CRP) was measured with a high-
sensitivity immunoassay. Data collected from assessments in 2005 and 2009were used to assess body mass index (BMI)
and CRP in young adulthood, before pregnancy. Robust regression models were implemented to evaluate BMI and CRP
in young adulthood as predictors of pregnancy CRP.
Results: Pre-pregnancy BMI was a stronger predictor of third-trimester circulating CRP than BMI in the third trimester. No
association was found between pregnancy weight gain and CRP. Pre-pregnancy CRP was a significant predictor of CRP in
pregnancy, independent of BMI.
Conclusions: Levels of overweight/obesity and inflammation in young adulthood, before pregnancy, are important
predictors of inflammation in the third trimester of pregnancy. These results may have implications for addressing the
growing concern about the contribution of obesity to adverse birth outcomes, and they suggest that factors that influence
the regulation of inflammation, before pregnancy and independent of adiposity, may be important in shaping the in-
flammatory response to pregnancy. J Nutr 2016;146:353–7.
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Introduction
Mild increases in inflammation are a normative part of healthy
pregnancy, but higher levels of inflammation during pre-
gnancy are associated with adverse birth outcomes (1, 2). For
example, circulating concentrations of C-reactive protein (CRP)
are elevated slightly among healthy pregnant women (3, 4), but
higher-than-normal concentrations in the third trimester predict
lower birth weight of offspring (5), preterm delivery (6), chronic
placental villitis (7), and preeclampsia (8). Increased inflammation
during pregnancy is also associated with gestational diabetes (9)
and risk of neurobehavioral disorders in offspring (10, 11).
Pregnancy complications and adverse birth outcomes increase
offspring risk of cardiovascular and metabolic diseases in adult-
hood, underscoring the importance of the gestational environment
to trajectories of health for the next generation (12, 13).
Adipose tissue is an important site of proinflammatory
cytokine production, and higher concentrations of CRP, outside
of pregnancy, are consistently associated with measures of
overweight and obesity (14, 15) and with elevated risk of
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cardiovascular disease (16) and type 2 diabetes (17). Obesity in
pregnancy also increases risk of gestational diabetes (18) and
preeclampsia and preterm delivery (19, 20). Chronic or
dysregulated inflammation, driven in part by excess adipose
tissue, may therefore be an important contributor to pregnancy
complications and adverse birth outcomes.
With rates of obesity on the rise, in the United States and
globally (21), several studies have documented positive associ-
ations between overweight/obesity and inflammation during
pregnancy (22). However, most prior studies have recruited
women after they become pregnant, with few studies that
included measures of adiposity and inflammation before preg-
nancy. Considering these factors in adulthood, before preg-
nancy, may be important for 2 reasons: 1) individual differences
in levels of adiposity and inflammation are apparent in adult-
hood and may be important determinants of how women respond
to the inflammatory stress of pregnancy; 2) identifying women who
are at increased risk of dysregulated inflammation during pregnancy,
before they become pregnant, may provide options for intervention
that reduce risk of pregnancy complications.
The aim of this study is to investigate the predictors of CRP in
the third trimester of pregnancy among a cohort of women in the
Philippines. The analysis uses data from a large, ongoing cohort
study with several rounds of data collection before the
pregnancy, to address the following specific objectives: 1)
evaluate whether BMI (in kg/m2) during pregnancy or BMI
before pregnancy is a stronger predictor of CRP in the third
trimester and 2) investigate whether CRP concentration before
pregnancy predicts CRP in the third trimester, independently of
BMI. The Philippines is a lower-middle income nation under-
going substantial economic, dietary, and lifestyle changes, and it
exemplifies current trends toward rising rates of overweight and
obesity globally and associated increases in cardiovascular and
metabolic diseases (23, 24).
Methods
Participants and data collection. The Cebu Longitudinal Health and
Nutrition Survey is an ongoing birth cohort study that began in 1983
with the recruitment of a community-based sample of 3327 pregnant
women (25). Offspring were followed through multiple rounds of data
collection, including surveys in young adulthood when participants were
20–22 (2005) and 24–26 (2009) y old. Cebu City is the second-largest
urban area in the Philippines, and the CLNHS is notable for the diverse
social, economic, and physical environments of study participants, who
inhabit agrarian communities, dense urban settlements, and middle-class
neighborhoods. Attrition in the Cebu Longitudinal Health and Nutrition
Survey is primarily because of factors related to out-migration, and rates
of refusal during initial recruitment were low (<4%) (25).
Between 2009 and 2014, when participants were 24–30 y old,
women were contacted at 6-mo intervals to identify new pregnancies. An
in-home interview was scheduled for the third trimester. Over the 5-y
period of pregnancy tracking the individual rate of pregnancy was 1.32
pregnancies per woman with a total of 82.7 pregnancies/y in the sample.
Rate of refusal was 1.2% of participants in the cohort, primarily because
of loss of contact, presumably resulting from out-migration. All data
were collected under conditions of informed consent with institutional
review board approval from Northwestern University.
Anthropometric measures were collected with the same standardized
procedures at each survey (26). Women provided information on
household demographic characteristics and socioeconomic status, preg-
nancy complications, and timing of last menstrual period. The mean
gestational timing of data collection was 29.6 wk from last menstrual
period, with 90% of interviews conducted between 26.0 and 35.4 wk.
Blood samples were collected as finger stick capillary whole blood,
dried on filter paper [dried blood spots (DBS)], for the analysis of CRP.
Each participants finger was cleanedwith alcohol, and a sterile, disposable
microlancet was used to deliver a controlled, uniform puncture. Whole
blood was placed directly on standardized filter paper commonly used for
neonatal screening (Whatman 903; GE Healthcare). This relatively
noninvasive blood collection protocol minimizes pain and inconvenience
to the participants, and it facilitates the collection of blood samples despite
the constraints of field-based research settings (27). After collection, DBS
cards were allowed to dry at room temperature for ;4 h and were stored
in gas-impermeable bags at220C before shipment. Samples were express
shipped to the United States where they were stored at 230C before
analysis.
Data from the 2005 and 2009 surveys were used to assess BMI and
CRP in young adulthood, before pregnancy. In 2005 and 2009, height
and weight were measured with the same standardized procedures. In
2005, venous blood samples were collected and measured for high-
sensitivity CRP, as described previously (14). BMI data from 2009 were
used to define pre-pregnancy BMI, unless women were pregnant at the
time of the survey, in which case BMI values from2005were used (n = 62).
Complete anthropometric, sociodemographic, and CRP data were
available for 409 pregnancies from 309 women. Over the 5-y period of
pregnancy tracking, 89 women were pregnant twice, and 11 women
were pregnant 3 times.
Measurement of circulating CRP. Samples were analyzed for CRP in
the Laboratory for Human Biology Research at Northwestern University
with the use of a modified high-sensitivity enzyme immunoassay
protocol previously developed for use with DBS (28). Prior validation
of assay performance indicates that the DBS CRP method produces
results that are comparable with gold standard plasma-based clinical
methods, with a lower limit of detection of 0.03 mg/L (28). To minimize
between-assay variation, all samples were analyzed by the same
technician with the use of a single lot of capture antibody, detection
antibody, and calibration material. Between-assay CVs for low, mid, and
high control samples included with all runs were 11.8%, 9.6%, and
8.1%, respectively.
Before data analysis, DBS results were converted to plasma equiv-
alent values with the use of a conversion formula that was based on 69
matched DBS and plasma samples (29). DBS samples were analyzed with
the same procedures, lot number of reagents, and technician as applied
to the study DBS samples. Plasma samples were analyzed for high-
sensitivity CRP in a high-throughput clinical laboratory on the Beckman
Coulter Synchron DXC platform. The correlation between DBS and
plasma concentrations was high (Pearson r = 0.98), and the resulting
Deming regression conversion formula was as follows: plasma (mg/L) =
1.64 3 DBS (mg/L).
Data analysis. Third-trimester CRP was the dependent variable in all
analyses, and CRP values were log-transformed (base 10) to normalize
the distribution. Pearson correlation coefficients were used to investigate
the strength of bivariate associations, and paired t test was used to
examine the difference in logCRP in young adulthood and logCRP in
pregnancy. A series of multivariate least-squares regression models were
implemented to determine the extent to which BMI and CRP before
pregnancy and BMI in pregnancy predicted CRP in pregnancy. To
facilitate interpretation, median CRP values are presented in the text and
in Figure 1, and untransformed values are presented in Figure 2, based on
predictions from the final regression model. Descriptive statistics in the
text are means 6 SDs, except for CRP, which is presented as median
(IQR). Regression coefficients are b (95% CI).
The sample includes 409 pregnancies, but because 100 women
provided data on $1 pregnancy, all observations are not independent.
Therefore, robust regression procedures were implemented that relax the
assumption of independence and produce SEs that account for clustered
observations (30). No sample weights or adjustments for missing
observations were applied to the analyses. Compared with other women
in the cohort, participants in the pregnancy study did not differ for years
of education, parity, or height or weight in young adulthood (all P > 0.3).
a < 0.05 was set as the criterion for statistical significance. All statistical
analyses were conducted with Stata/SE for Windows, version 13.1
(StataCorp).
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Preliminary analyses indicated that the timing of data collection in
the third trimester was not significantly associated with CRP (b = 0.01;
95% CI:20.03, 0.05; P = 0.7) and was therefore not considered further.
Women who were pregnant in the 2005 survey were not included in this
analysis because they did not have a CRP measurement when they were
not pregnant.
Several variables were considered as potential confounders/modifiers
of associations with pregnancy CRP. Multiple measures of socioeco-
nomic status (education level, home ownership, assets) were assessed as
part of the pregnancy interview. Information on pregnancy complica-
tions was also collected, including self-reports of gestational diabetes,
high blood pressure, urinary tract infection, and placenta previa.
Overall, 19.2% of the pregnancies were associated with $1 complica-
tion. Information on diet during pregnancy was also considered. Women
were asked to report on the number of meals and snacks they typically
eat in a day and the frequency of fast-food consumption in a month.
They were also asked to report on what foods they usually eat for
breakfast, lunch, dinner, and snack. This information was summarized
by category, to provide measures of the daily frequency of consumption
of the following foods: meat (pork, beef, goat, chicken), fish and
crustaceans, bread/baked goods, and rice (various preparations).
Results
Mean pre-pregnancy BMI in the sample was 21.4 6 3.5, mean
BMI in the third trimester was 24.5 6 3.4, and women gained
7.3 6 5.0 kg from their pre-pregnancy weight (Table 1). With
the use of WHO-recommended BMI cutoff values, 15.3% of the
women were overweight or obese as young adults, before
pregnancy. However, WHO analyses have also acknowledged
increased risk of cardiovascular and metabolic diseases in Asian
populations, including the Philippines, at BMI < 25 (31). After
prior research in this cohort (32), the use of 23 as the BMI cutoff
for overweight and 25 as the BMI cutoff for obesity indicated a
rate of overweight/obesity of 27.3%. Consistent with prior
reports that levels of central body fat are higher among some
Asian population at a given BMI value compared with white/
European populations (33), mean waist-hip ratio in the sample
was 0.88, and 81.4% of the sample was >0.85, the WHO cutoff
for increased metabolic risk (34).
Median CRP before pregnancy was 0.3 mg/L (IQR: 0.09, 1.3
mg/L), and it increased significantly in the third trimester to 1.8
mg/L (IQR: 1.0, 3.1 mg/L) (t = 217.5, P < 0.001, for difference
between logCRP before and during pregnancy). Pregnancy CRP
was positively associated with BMI before pregnancy (Figure 1).
Similarly, concentration of CRP in young adulthood was
positively associated with BMI in young adulthood, as reported
previously in this cohort (14). As expected, pre-pregnancy BMI
and BMI in the third trimester of pregnancy were highly
correlated (r = 0.80, P < 0.001).
We next examined the predictors of third-trimester CRP in
multivariate regression analyses. In preliminary analyses we
found that primiparous women had significantly lower CRP
during pregnancy (b =20.11; 95%CI:20.20,20.02; P < 0.05).
We therefore included this variable and maternal age (b = 0.05;
95% CI: 20.05, 0.14; P = 0.4) in subsequent models.
BMI during pregnancy was significantly and positively
associated with CRP (b = 0.028; 95% CI: 0.015, 0.041; P <
0.001). The association between pre-pregnancy BMI and CRP,
however, was slightly stronger (Table 2, model 1), and the model
R2 was higher (0.10 compared with 0.09), indicating a larger
proportion of explained variance in logCRP. When both BMI
variables were considered simultaneously, pre-pregnancy BMI
was a significant predictor of CRP (b = 0.025; 95% CI: 0.007,
0.043; P < 0.01), whereas BMI in pregnancy was not (b = 0.009;
95% CI: 20.012, 0.030; P = 0.4).
Because BMI values before and during pregnancy were highly
correlated, it is difficult to distinguish their independent associa-
tions withCRP.We therefore calculated a variable that represented
BMI gain in pregnancy (BMIpregnancy 2 BMIpre-pregnancy), which is
only moderately correlated with the BMI before pregnancy (r =
20.28, P < 0.001) and third-trimester BMI (r = 0.35, P < 0.001).
Because height did not change across the pre-pregnancy and
pregnancy measurements, BMI gain can also be interpreted as
representing weight gain during pregnancy. BMI gain was not a
significant predictor of third-trimester CRP, whereas pre-
pregnancy BMI remained a strong predictor (Table 2, model 2).
FIGURE 1 Median CRP concentration during young adulthood and
pregnancy in relation to pre-pregnancy BMI in young women in the
Philippines. The number of women in each BMI category is presented
above the open bars; the number of pregnancies in each BMI category
is presented above the closed bars. There were 409 pregnancies in
309 women overall. CRP, C-reactive protein.
FIGURE 2 CRP concentrations during pregnancy in young women
in the Philippines as predicted by the pre-pregnancy concentration,
adjusted for other variables in Model 3, Table 2. The 95% CI is
represented by dashed lines. There were 409 pregnancies in 309
women overall. CRP, C-reactive protein.
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We next evaluated whether CRP, measured before pregnancy,
was an independent predictor of CRP in the third trimester.
When considered in a model with age and primiparity, pre-
pregnancy CRP was a strong and significant predictor of CRP in
pregnancy (b = 0.136; 95% CI: 0.064, 0.207; P < 0.001). When
pre-pregnancy BMI was added to the model, pre-pregnancy CRP
remained as an independent predictor of CRP in the third
trimester, and the association between pre-pregnancy BMI and
pregnancy CRP was attenuated (Table 2, model 3). The model
R2 is higher when pre-pregnancy CRP is included (0.14
compared with 0.10), further underscoring the predictive value
of pre-pregnancy CRP. Figure 2 shows CRP in pregnancy as a
function of CRP before pregnancy, independent of BMI and
other covariates in the final model.
Finally, we considered several sets of variables as potential
confounders of associations with pregnancy CRP (results not
shown). Measures of socioeconomic status (home ownership,
maternal education, household assets) did not approach signif-
icance as predictors of pregnancy CRP. We also confirmed that
the pattern of results did not differ across primiparous compared
with multiparous pregnancies by running separate models for
each. Similarly, pregnancy complications, and measures of food
frequency, did not modify patterns of association between
pregnancy CRP and other variables in the final model.
Discussion
Pregnancy is an inflammatory event, and effective regulation of
inflammation is an important part of healthy pregnancy.
Inflammation is also associated with overweight and obesity,
but the extent to which additional adipose tissue, before or
during pregnancy, may contribute to excessive inflammation is
not known. In this study we take advantage of data from a
prospective cohort study to investigate the extent to which BMI
and inflammation in young adulthood, before pregnancy, predict
the inflammatory response to pregnancy.
Consistent with prior research, across a wide range of
populations, we find a positive association between BMI and
CRP in pregnancy (35–37). However, our results suggest that
BMI in adulthood, before pregnancy, is a stronger predictor of
CRP in pregnancy. Cross-sectional studies do not include pre-
pregnancy BMI, raising the possibility that prior reports of an
association between BMI and CRP in pregnancy reflect the
strong correlation between BMI before pregnancy and BMI in
pregnancy. Consistent with this idea, a study of healthy pregnant
women (9) documents a strong positive association between
pre-pregnancy BMI and late second/early third-trimester CRP,
with no association between CRP and pregnancy weight gain.
Similarly, we find no association between pregnancy weight gain
and CRP in our sample.
The clinical implications of our findings are not clear and will
require additional research. Elevations in CRP are a normative
part of healthy pregnancy (3, 4), but excessive inflammation was
associated with adverse birth and developmental outcomes in a
wide range of populations globally (5–11). Our results may have
important implications for addressing growing concern about the
contribution of overweight and obesity to adverse birth outcomes,
because it appears that limiting weight gain during pregnancy
may not be effective in reducing levels of inflammation.
To the best of our knowledge, this study is the first to report
an association between the level of systemic inflammation in
adulthood, before pregnancy, and the inflammatory response
to pregnancy. We find a strong positive association that is
independent of BMI. Although prior research has emphasized
the potential for synergy between pregnancy and adiposity
for increasing levels of inflammation during gestation (22, 36),
our findings suggest that additional factors that contribute to the
regulation of inflammation, before pregnancy and independent of
adiposity, may be important in shaping the inflammatory response
to pregnancy. For example, prior research has identified nutritional
and microbial exposures in infancy (38, 39) and psychosocial
stressors in childhood (40) as important determinants of chronic
inflammation in adulthood. These kinds of exposures, during
sensitive periods of immune development, may therefore have
lasting effects on the inflammatory response to pregnancy (41).
A major strength of our study is the use of a large, prospective,
community-based cohort, with measures of adiposity and inflam-
mation collected before pregnancy. A limitation is our use of
single CRP measures to assess chronic inflammation, both in
adulthood and during pregnancy. Similarly, because we have only
1 pregnancy CRP measure, we cannot determine the level of
inflammation earlier in gestation. In addition, the average BMI in
our sample is relatively low at 21.4, compared with an average
BMI of ;26 for comparably aged young women in the United
States (42). As such, generalizability may be limited, although we
TABLE 2 Linear regression coefficients that describe the associations between age, parity, BMI before
pregnancy, BMI gain in pregnancy, and circulating CRP before pregnancy and log-transformed circulating
CRP in the third trimester in young women in the Philippines1
Characteristic Model 1 Model 2 Model 3
Age, y 0.078* (20.010, 0.165) 0.080* (20.007, 0.167) 0.076* (20.006, 0.158)
Primiparity 20.064 (20.154, 0.026) 20.067 (20.156, 0.022) 20.048 (20.133, 0.038)
BMI before pregnancy, kg/m2 0.032*** (0.021, 0.043) 0.034*** (0.022, 0.046) 0.028*** (0.014, 0.043)
BMI gain, kg/m2 0.009 (20.012, 0.030) 0.009 (20.011, 0.029)
logCRP before pregnancy 0.104** (0.031, 0.176)
Model R 2 0.10 0.10 0.14
1 Values are b (95% CI); n = 409 pregnancies from 309 women. *P , 0.10, **P , 0.01, and ***P , 0.001.
TABLE 1 Descriptive characteristics of the study participants1
Characteristic Value
Age, y 27.0 6 1.5 (24.4–30.2)
Parity 2.8 6 1.6 (1–10)
Education, y 12.0 6 4.2 (1–23)
Waist-hip ratio, before pregnancy 0.88 6 0.04 (0.78–0.96)
BMI, kg/m2
Before pregnancy 21.4 6 3.5 (14.9–34.8)
Third trimester 24.5 6 3.4 (16.6–38.2)
1 Values are means 6 SDs (range), n = 409 pregnancies from 309 women.
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note that the patterns of association between BMI, pregnancy,
and CRP in our sample are consistent with prior research in the
United States and other international settings. In addition, the
range of BMI in our sample includes a substantial number of
overweight/obese individuals, andmost women in our sample had
waist-hip ratio above the WHO cutoff for increased metabolic
risk, which should enhance generalizability to more obesigenic
environments. Additional research in this and other populations
may generate novel insights into the factors that contribute to
inflammation during pregnancy, with implications for birth
outcomes and trajectories of health in the next generation.
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